Kadcyla-100mg (Trastuzumab emtansine Vials) 100mg

Kadcyla (trastuzumab emtansine) 100mg vials are a targeted therapy for certain cancers. This prescription medication is used under medical supervision for HER2-positive breast cancer treatment. Store between 2-8°C to maintain potency.

Strength

100mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Genentech, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab emtansine is prescribed for HER2-positive breast cancer in patients who have previously received trastuzumab and a taxane. It combines an antibody with a chemotherapy agent to target cancer cells specifically. This medication is typically used after other treatments have been attempted. Patients may ask what trastuzumab emtansine is used for when discussing treatment options with their healthcare provider.

Side Effects

This medication works by binding to HER2-positive cancer cells and delivering chemotherapy directly to them. Patients may experience side effects like fatigue, nausea, or headache during treatment. Some people report changes in appetite or mild skin reactions. These effects vary widely between individuals and should be discussed with a healthcare professional.

Precautions & Warnings

Keep Kadcyla vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials. Handle with care to avoid contamination. Always follow your healthcare provider's instructions for preparation and administration. Report any unusual symptoms immediately to your medical team.

Avoid Interactions

Trastuzumab emtansine may interact with other medications that affect liver enzymes, including certain antibiotics and antifungals. Blood thinners and medications that lower heart function may require monitoring. Always inform your healthcare provider about all medications you're taking. Some herbal supplements can also interact with this treatment.

Frequently Asked Questions

It is prescribed for HER2-positive breast cancer in patients who have received prior trastuzumab and taxane therapy.

This medication is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common effects may include fatigue, nausea, headache, or changes in appetite during treatment.

No, Kadcyla must be refrigerated between 2-8°C and protected from light.

It combines targeted therapy with chemotherapy, delivered specifically to cancer cells.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.